(87 days)
Not Found
No
The device description and performance studies focus on the physical properties and performance of a PICC catheter, with no mention of AI or ML technologies.
No
The device is a peripherally inserted central catheter (PICC) used for administering fluids, blood products, drugs, and parenteral nutrition, as well as for blood withdrawal and power injection of contrast media. While it delivers substances that may be therapeutic, the device itself is a delivery system, not a therapeutic agent that treats a disease or condition.
No
The device is described as a PICC (Peripherally Inserted Central Catheter) used for administering fluids, blood products, drugs, and for blood withdrawal, not for diagnosing conditions.
No
The device description clearly details a physical catheter made of polyurethane with various hardware components like hubs, suture wings, clamps, and luer connectors. It also mentions accessories for insertion. This is a hardware medical device, not software-only.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device for accessing the central venous system for administering fluids, drugs, and nutrition, as well as blood withdrawal and power injection of contrast media. These are all direct interactions with the patient's circulatory system.
- Device Description: The description details a catheter designed for central venous catheterization, made of polyurethane, with features for insertion and connection to administration systems. This is a medical device used in vivo (within the body).
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is used in vivo to access the central venous system.
N/A
Intended Use / Indications for Use
The PFM PICC is indicated for short or long term access to the central venous system. It is designed for administering IV fluids, blood products, drugs and parenteral nutrition solutions, as well as blood withdrawal and power injection of contrast media. The maximum recommended infusion rate is 5 cc/sec. The maximum pressure of power injectors used with the PFM PICC may not exceed 300 psi.
Product codes
LJS
Device Description
The PFM Medical PFM PICC Catheters are designed for central venous catheterization. The PFM PICC lumen is comprised of a soft radiopaque polyurethane material. The lumen is connected to the extensions via a soft pliable hub with suture wing for secure placement. Cuff attachment to the lumen provides for tissue ingrown. Clamps are provided on the extension tubes to prevent airfluid communication. Female luer connectors provide the connection for intravenous administration. The catheters are available in 3F, 4F, 5F and 6F single lumen versions, and 4F, 5F and 6F in double lumen versions. The catheters are up to 60 cm in length with depth markings in 5 cm increments. Stylet and adaptor sideport is provided to assist in catheter insertion.
The catheters can be used in the injection of contrast media. The maximum recommended infusion rate is 5 cc/sec. The maximum pressure of power injectors used with the PFM PICC catheter may not exceed 300psi
The PFM PICC product line is packaged with the necessary accessories for a percutaneous microintroducer introduction (Modified Seldinger or Seldinger technique).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
central venous system
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
In vitro testing was performed on the PFM PICC to assure reliable design and performance in accordance with ISO 10555-1 and 105553. Testing includes air/liquid leakage, cuff shear, force at break, elongation, gravity flow, static burst pressure, high pressure injection flow rate and chemical testing.
Clinical studies were not deemed necessary since in vitro testing was sufficient to demonstrate safety and effectiveness by way of comparison to legally marketed predicate device.
Biocompatibility testing on the PFM PICC demonstrates that the materials used meet the requirements of ISO 10993 for a permanent contact device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5970 Percutaneous, implanted, long-term intravascular catheter.
(a)
Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”
0
Image /page/0/Picture/0 description: The image contains handwritten text that appears to be a combination of letters and numbers. The text reads "K072391 (G.I.ens)". The characters are written in a casual, slightly slanted style, and the contrast between the ink and the background is high, making the text easily readable.
510(k) Summary of Safety and Effectiveness
The following section is included as required by the Safe Medical Device Act (SMDA) of 1990.
| Name: | PFM Medical, Inc |
|---|---|
| Address: | 2605 Temple Heights Drive |
| Suite A | |
| Oceanside, CA 92056 | |
| CONTACT PERSON: | SALVADORE F. PALOMARES, RAC |
NOV 1 9 2007
510(k) Summary of Safety and Effectiveness
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: Trade Name: PFM PICC Common Name: Catheter, Intravascular, Therapeutic, Long Term Classification: LSS
Equivalent Devices: Manufacturer: MedComp Name: PRO-LINE CT Power Injectable CVC 510(k) #: K053345
Device Description:
The PFM Medical PFM PICC Catheters are designed for central venous catheterization. The PFM PICC lumen is comprised of a soft radiopaque polyurethane material. The lumen is connected to the extensions via a soft pliable hub with suture wing for secure placement. Cuff attachment to the lumen provides for tissue ingrown. Clamps are provided on the extension tubes to prevent airfluid communication. Female luer connectors provide the connection for intravenous administration. The catheters are available in 3F, 4F, 5F and 6F single lumen versions, and 4F, 5F and 6F in double lumen versions. The catheters are up to 60 cm in length with depth markings in 5 cm increments. Stylet and adaptor sideport is provided to assist in catheter insertion.
The catheters can be used in the injection of contrast media. The maximum recommended infusion rate is 5 cc/sec. The maximum pressure of power injectors used with the PFM PICC catheter may not exceed 300psi
The PFM PICC product line is packaged with the necessary accessories for a percutaneous microintroducer introduction (Modified Seldinger or Seldinger technique).
Intended Use:
The PFM PICC is indicated for short or long term access to the central venous system. It is designed for administering IV fluids, blood products, drugs and parenteral nutrition solutions, as well as blood withdrawal and power injection of contrast media. The maximum recommended infusion rate is 5 cc/sec. The maximum pressure of power injectors used with the PFM PICC may not exceed 300 psi.
1
K
$$i$$
73391(
$$C.2+2$$
)
Performance Data:
In vitro testing was performed on the PFM PICC to assure reliable design and performance in accordance with ISO 10555-1 and 105553. Testing includes air/liquid leakage, cuff shear, force at break, elongation, gravity flow, static burst pressure, high pressure injection flow rate and chemical testing.
Clinical studies were not deemed necessary since in vitro testing was sufficient to demonstrate safety and effectiveness by way of comparison to legally marketed predicate device.
Biocompatibility:
Biocompatibility testing on the PFM PICC demonstrates that the materials used meet the requirements of ISO 10993 for a permanent contact device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines representing its wings. To the left of the eagle is the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" arranged in a circular fashion.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 1 9 2007
Mr. Salvadore F. Palomares, RAC Director of Regulatory Affairs PFM Medical, Incorporated 2605 Temple Heights Drive, Suite A Oceanside, California 92056
Re: K072391
Trade/Device Name: PFM PICC Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, Implanted, Long-Term Intravascular Catheter Regulatory Class: II Product Code: LJS Dated: October 15, 2007 Received: October 16, 2007
Dear Mr. Palomares:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Image /page/3/Picture/2 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features a stylized eagle with three lines forming its body and wings. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Page 2 - Mr. Palomares
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Nil R. Syal
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k):
Device Name: PFM PICC
The PFM PICC is indicated for short or long term Indications for Use: access to the central venous system. It is designed for administering IV fluids, blood products, drugs and parenteral nutrition solutions, as well as blood withdrawal and power injection of contrast media. The maximum recommended infusion rate is 5 cc/sec. The maximum pressure of power injectors used with the PFM PICC may not exceed 300 psi.
X_____________________________________________________________________________________________________________________________________________________________________________ Over the Counter Use Prescription Use (Per 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(Please Do Not WRITE BELOW THIS LINE - Continue on Another PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Antony W. Nunez
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: